Investors in Health

Scranton Enterprises B.V. is a dynamic financial services company headquartered in Amsterdam, Netherlands. Specializing in a wide range of financial solutions, Scranton Enterprises B.V. offers expertise in investment management, asset allocation, and financial advisory services tailored to meet the diverse needs of clients. With a strategic presence in Amsterdam, a global financial hub, the company leverages its location to access international markets and opportunities. Scranton Enterprises B.V. prides itself on delivering personalized financial strategies and innovative solutions that align with client objectives and market dynamics. Committed to excellence and integrity, the firm maintains a client-centric approach, ensuring transparency and trust in all business dealings.

Impact X Capital Partners is a double bottom line venture capital firm committed to supporting underrepresented entrepreneurs across Europe. Focused on fostering diversity and inclusion, Impact X provides strategic capital and mentorship to innovative startups led by minority founders. Their investment approach aims to generate both financial returns and positive social impact, driving economic growth and equity in the startup ecosystem. By empowering diverse entrepreneurs, Impact X Capital Partners strives to create lasting change and opportunity within the venture capital landscape.

Noa Capital operates as an investment advisory firm, offering strategic guidance and advisory services to optimize financial decisions for clients. Specializing in providing personalized investment advice, Noa Capital assists individuals and institutions in navigating diverse investment opportunities effectively. With a focus on delivering tailored solutions, they aim to support clients in achieving their financial objectives through comprehensive analysis and expert insights.

O2h Ventures is an investment firm specializing in biotechnology, providing investors with opportunities to support promising medical innovations through the EIS (Enterprise Investment Scheme) and SEIS (Seed Enterprise Investment Scheme). Focused on backing groundbreaking biotech ventures, O2h Ventures facilitates investments that contribute to advancements in healthcare and medical science, leveraging tax-efficient investment schemes to enhance potential returns for investors.

Eight Roads Ventures is a global investment firm dedicated to backing bold and transformative entrepreneurs across diverse industries. With a heritage spanning over 50 years, we have built a robust portfolio that includes technology, healthcare, consumer, and financial services sectors. Our mission is to support innovative companies at various stages of growth, from early-stage startups to established enterprises, helping them scale and achieve long-term success. With offices in key markets such as Europe, Asia, and the United States, we leverage our international network to provide strategic insights and connect our portfolio companies with opportunities worldwide. Our team of experienced professionals brings deep industry knowledge, offering strategic guidance, operational support, and access to a global network of resources. Committed to investing in companies that drive innovation and have a positive impact, we have a proven track record of helping businesses achieve significant milestones.

Eka Ventures partners with founders who are pioneering category-defining technology companies. They focus on ventures that contribute positively to sustainability, health, and inclusivity, aiming to reshape industries and create a more equitable world. By backing innovative startups, Eka Ventures plays a pivotal role in advancing solutions that address global challenges, supporting initiatives with potential for significant social and environmental impact.

Trois I Investissements Industriels Internationaux sa is an independent, family owned holding company focused on long term investments. ‍ Established in the late ‘90s in London, Trois I moved to Luxembourg in 2006, with the aim to take advantage of the country’s potential as an EU based financial platform.

Careventures is an independent pan-European private equity firm that invests in high-growth and profitable small and mid-cap companies in the healthcare services sector. Founded in 2014 by four senior partners bringing together substantial investment, operational and entrepreneurial experience in sizeable and successful multinational healthcare ventures, with over 100 investments executed within healthcare services over two decades. Careventures builds and grows successful business platforms in unconsolidated niches within European healthcare services by executing multiple follow-on acquisitions, accurately addressing and exploiting technological shifts and/or changes in regulatory environments.

De Friesland recognizes that innovation is crucial for ensuring the accessibility and affordability of healthcare. That's why we actively invest in numerous organizations and projects dedicated to shaping a sustainable healthcare landscape. By supporting innovative initiatives, we aim to enhance the quality of care while addressing healthcare challenges effectively. Our commitment extends to fostering collaborations and partnerships that drive meaningful advancements in the sector.

Capital Mills, established in 2016, bridges the gap between individual angel investors and traditional investment funds through a robust network comprising over 50 investors. Focused primarily on technology ventures, all investors at Capital Mills boast entrepreneurial backgrounds, bringing invaluable expertise and insight to the table. This network proves highly beneficial to the companies they fund, providing not just capital but also strategic guidance and operational support. Capital Mills operates with an agile investment team dedicated to day-to-day operations, ensuring efficient and effective engagement with portfolio companies. This proactive approach enhances the growth trajectory of their investments, fostering sustainable development and maximizing value creation.

RUG Holding is a venture capital firm dedicated to investing in innovative companies within the biotechnology and regulated business sectors. With a strategic focus on fostering advancements in biotech and regulated industries, RUG Holding identifies promising startups and growth-stage enterprises poised for impactful growth and development. The firm provides essential capital, strategic guidance, and operational support to empower portfolio companies in navigating complex regulatory landscapes and accelerating market adoption. By leveraging its expertise and network, RUG Holding aims to drive innovation, facilitate industry leadership, and create sustainable value for its stakeholders. Positioned at the intersection of science, technology, and regulation, RUG Holding plays a crucial role in shaping the future of biotech and regulated markets.

Keen Venture Partners is a prominent venture capital firm based in London, specializing in growth-stage investments across technology-enabled sectors in Europe. Since its inception, Keen Venture Partners has been dedicated to supporting entrepreneurial ventures with innovative technologies and scalable business models. Focusing on areas such as enterprise software, digital media, consumer internet, and healthcare technology, the firm provides capital primarily during Series A and Series B funding rounds. Beyond financial backing, Keen Venture Partners offers strategic guidance and operational expertise to help portfolio companies navigate complexities, expand market presence, and accelerate product development. With a robust network of industry experts and advisors, Keen Venture Partners aims to foster sustainable growth and drive market disruption within the European tech ecosystem, contributing to the advancement of innovative solutions and entrepreneurial success.